| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2012 | A regularly spaced and self-revealing protein ladder for anti-tag Western blot analysis. | Kao, CH; Cheng, CM; Chuang, KH; Chuang, CH; Tzou, SC; Cheng, TC; Hsieh, YC; Liao, KW; Wang, YM; Chang, LS; Roffler, SR; Chen, FM; Cheng, TL | Analytical Biochemistry 431(1), 1-3 | | | |
| 2016 | A Secondary Antibody-Detecting Molecular Weight Marker with Mouse and Rabbit IgG Fc Linear Epitopes for Western Blot Analysis. | Lin, WW; Chen, IJ; Cheng, TC; Tung, YC; Chu, PY; Chuang, CH; Hsieh, YC; Huang, CC; Wang, YT; Kao, CH; Roffler, SR; Cheng, TL | PloS one 11(8), e0160418 | | | |
| 2012 | An activity-based near-infrared glucuronide trapping probe for imaging beta-glucuronidase expression in deep tissues. | Cheng, TC; Roffler, SR; Tzou, SC; Chuang, KH; Su, YC; Chuang, CH; Kao, CH; Chen, CS; Harn, IH; Liu, KY; Cheng, TL; Leu, YL | Journal of the American Chemical Society 134(6), 3103-3110 | | | |
| 2010 | Development of an universal anti-polyethylene glycol reporter gene for non-invasive imaging of PEGylated probes | Chuang, KH; Wang, HE; Cheng, TC; Tzou, SC; Cheng, CM; Kao, CH; Chuang, CH; Tseng, WL; Hung, WC; Lin, SR; Chen, BM; Roffler, SR; Cheng, TL | JOURNAL OF NUCLEAR MEDICINE 51,933-941 | | | |
| 2015 | Discovery of Specific Inhibitors for Intestinal E. coli beta-Glucuronidase through In Silico Virtual Screening. | Cheng, TC; Chuang, KH; Roffler, SR; Cheng, KW; Leu, YL; Chuang, CH; Huang, CC; Kao, CH; Hsieh, YC; Chang, LS; Cheng, TL; Chen, CS | TheScientificWorldJournal 2015, 740815 | | | |
| 2022 | FAK Executes Anti-Senescence via Regulating EZH2 Signaling in Non-Small Cell Lung Cancer Cells | Chuang, HH; Huang, MS; Zhen, YY; Chuang, CH; Lee, YR; Hsiao, M ; Yang, CJ | BIOMEDICINES 10(8), 1937 | | | |
| 2022 | FAK in Cancer: From Mechanisms to Therapeutic Strategies | Chuang, HH; Zhen, YY; Tsai, YC; Chuang, CH; Hsiao, M ; Huang, MS; Yang, CJ | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 23(3), 1726 | | | |
| 2014 | High-throughput sorting of the highest producing cell via a transiently protein-anchored system. | Chuang, KH; Hsieh, YC; Chiang, IS; Chuang, CH; Kao, CH; Cheng, TC; Wang, YT; Lin, WW; Chen, BM; Roffler, SR; Huang, MY; Cheng, TL | PloS one 9(7), e102569 | | | |
| 2011 | In vivo positron emission tomography imaging of protease activity by generation of a hydrophobic product from a non-inhibitory protease substrate. | Cheng, TL; Chuang, CH; Chuang, KH; Wang, HE; Roffler, SR; Shiea, JT; Tzou, SC; Wu, SY; Cheng, TC; Kao, CH; Cheng, CM; Tseng, WL; Hou, MF; Wang, JM | CLINICAL CANCER RESEARCH 18(1), 238-247 | | | |
| 2022 | Inhibition of gut microbial β-glucuronidase effectively prevents carcinogen-induced microbial dysbiosis and intestinal tumorigenesis | Cheng, KW; Tseng, CH; Chen, IJ; Huang, BC; Liu, HJ; Ho, KW; Lin, WW; Chuang, CH; Huang, MY; Leu, YL; Roffler, SR ; Wang, JY; Chen, YL; Cheng, TL | Pharmacological research 177, 106115 | | | |
| 2014 | One-step mixing with humanized anti-mPEG bispecific antibody enhances tumor accumulation and therapeutic efficacy of mPEGylated nanoparticles. | Kao, CH; Wang, JY; Chuang, KH; Chuang, CH; Cheng, TC; Hsieh, YC; Tseng, YL; Chen, BM; Roffler, SR; Cheng, TL | Biomaterials 35(37), 9930-9940 | | | |
| 2014 | PET Imaging of beta-Glucuronidase Activity by an Activity-Based 124I-Trapping Probe for the Personalized Glucuronide Prodrug Targeted Therapy. | Su, YC; Cheng, TC; Leu, YL; Roffler, SR; Wang, JY; Chuang, CH; Kao, CH; Chen, KC; Wang, HE; Cheng, TL | Molecular Cancer Therapeutics 13(12), 2852-2863 | | | |
| 2021 | Targeting Pin1 for Modulation of Cell Motility and Cancer Therapy | Chuang, HH; Zhen, YY; Tsai, YC; Chuang, CH; Huang, MS; Hsiao, M ; Yang, CJ | BIOMEDICINES 9(4), 359 | | | |
| 2016 | Using anti-poly(ethylene glycol) bioparticles for the quantitation of PEGylated nanoparticles. | Hsieh, YC; Cheng, TC; Wang, HE; Li, JJ; Lin, WW; Huang, CC; Chuang, CH; Wang, YT; Wang, JY; Roffler, SR; Chuang, KH; Cheng, TL | Scientific reports 6, 39119 | | | |
